Integra Biosciences, a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation, announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols.
This acquisition will allow Integra to expand its product range for library preparation, offering significant time savings to academic, research and diagnostics laboratories using NGS and, ultimately, accelerating discovery in this dynamic field.
Miroculus is based in San Francisco, California, and was founded to develop innovative and intuitive tools that simplify complex genomics protocols, making them accessible to a wider range of scientists. Urs Hartmann, CEO of Integra, said:
